scholarly journals Treatment of Motor Symptoms in Idiopathic Parkinson’s Disease

2015 ◽  
Vol 3 (2) ◽  
pp. 43-47
Author(s):  
Elif GOKCAL ◽  
Gulsen BABACAN YILDIZ
2018 ◽  
Vol 56 (5) ◽  
pp. 54-57

▼ Safinamide (Xadago - Zambon S.p.A) is a monoamine-oxidase B (MAO-B) inhibitor licensed as add-on therapy for people with idiopathic Parkinson’s disease who are experiencing motor fluctuations with levodopa.1 Currently there is no cure for Parkinson’s disease and drugs are used to reduce motor symptoms and improve daily activities.2,3 Here, we review the evidence for this MAO-B inhibitor.


2021 ◽  
Vol 429 ◽  
pp. 119601
Author(s):  
Domiziana Rinaldi ◽  
Michela Sforza ◽  
Lanfranco De Carolis ◽  
Marika Alborghetti ◽  
Edoardo Bianchini ◽  
...  

Author(s):  
Fatma Genç ◽  
Abidin Erdal ◽  
Yasemin Biçer Gömceli ◽  
Aysun Tıltak ◽  
Cenk Altunç ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document